Viewing Study NCT07020260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 6:46 PM
Study NCT ID: NCT07020260
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-13
First Post: 2025-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Sponsor: Princess Maxima Center for Pediatric Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module